On July 31, 2023, Mendus AB (publ), closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 SEK | -5.15% | +1.96% | -10.42% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.42% | 45.04M | |
+29.59% | 48.16B | |
-0.75% | 41.73B | |
+43.17% | 41.03B | |
-5.31% | 28.77B | |
+10.17% | 25.59B | |
-22.52% | 18.96B | |
+9.32% | 12.92B | |
+28.69% | 12.03B | |
-2.30% | 11.77B |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Mendus AB announced that it has received funding from Flerie Invest AB